Paris closing: the CAC40 drops 1.44%


(Boursier.com) – THE TREND

The CAC40 which had started the session slightly up finally gave up 1.44%, back to 7.115 points. After a fanfare start to the year and three sessions that brought it to new historical records of almost 7,400 points, the Parisian index remains in decline pending the season of annual publications. This Monday, Atos sent the wrong message with a new warning on its 2021 performance. The title lost 16.8% this evening!

ECO AND CURRENCIES

Isabel Schnabel, one of the ECB’s executive board, said over the weekend that the ECB could react if the rise in energy prices persisted, thus following in the wake of the stronger Fed rhetoric as we know since last Thursday … The next big meeting for investors is set for this Wednesday with the monthly statistics of American consumer prices, the increase in annual rate could reach 7% according to the Reuters consensus. The week will also be animated by the hearings of Jerome Powell and Lael Brainard in the Senate before the probable renewal of their mandate at the head of the Federal Reserve …

RISING VALUES

Claranova : + 6.7% followed by Manitou (+ 5%) and Parrot

Dare : + 4.5% boosted by a recommendation from Degroof Petercam, with the purchase on the file with a target price of 15.52 euros. Ubisoft, Ramsay and Aures go up by more than 4%.

Mercialys : + 3.5% with Vetoquinol, Cegedim, Elis, Klepierre and Genfit

Trigano : + 2.5% with Alstom, Derichebourg (+ 1.8%)

Alstom (+ 1.8%) won a new order to supply DB Regio with 17 high capacity Coradia Stream trains for the Main-Weser network in Germany. Commissioning is scheduled for December 15, 2024. Commissioning is scheduled for December 15, 2024. Alstom will assemble the trains at its site in Salzgitter, Germany.

Thales : + 1.5% with Innate, Icade, ADP, EDF (+ 1%) followed by Air France KLM, Groupe Crit

FALLING VALUES

Atos plunges nearly 17%. The group has issued a warning on its annual results mainly because of items that it considers to be non-recurring. Compared to the objectives set last July, the management announced, for the 2021 financial year, a preliminary turnover of 10.8 billion euros, down around 2.4% at exchange rates. constant, an operating margin of around 4% and free cash flow of around -420 million euros. Results to be compared with the previous guidance, ie stable revenues, an operating margin of around 6% and a “positive” free cash flow.

Abivax : -8% followed by Valneva (-7%) and Sartorius (-6.5%) with LFE

Antin : -5.5% with SII, Vallourec, Wavestone, Worldline, BioMerieux

Hermes, which remained on two sessions of marked decline, lost another 5%. A selling pressure this time linked to a note from UBS which downgraded the title of the luxury group to ‘neutral’ despite an objective raised from 1,475 to 1,610 euros.

Eurofins Scientific fell nearly 5% on Monday, as Jefferies lowered its “hold” recommendation against a “buy” notice previously. The broker has nevertheless adjusted its price target from 92 to 100 euros.

Schneider : -5% followed by S30, Groupe Gorgé

STM : -4% with Transgene, Carrefour

L’Oreal : -3.5% with Alten



Source link -87